510(k) K183230
K183230 is an FDA 510(k) premarket notification submitted by Drawbridge Health, Inc. for the device "OneDraw A1C Test System". The FDA issued a decision of Substantially Equivalent on Aug 15, 2019. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470. Drawbridge Health, Inc. has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 15, 2019
- Date Received
- Nov 20, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type
- 510(k)
Need the full FDA record for Drawbridge Health, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.